FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and aims at suppressing, preventing or controlling myopia progression. The group involves contact lenses having optics for myopia control in a combination with therapeutic agents also known as agents for myopia control, namely muscarine receptor antagonists and dopamine agonists.
EFFECT: group of inventions enables providing the drug delivery mechanisms for delaying or arrest myopia progression in the patients.
14 cl, 5 tbl, 12 dwg
Authors
Dates
2015-08-20—Published
2013-07-30—Filed